Showing results (1-10 of 163) with videos related to
Sort By:
Pageof 17
Annual Review of Pharmacology and Toxicology|October 29, 2013
GABAA receptor subtypes: Therapeutic potential in Down syndrome, affective disorders, schizophrenia, and autismUwe Rudolph, Hanns MöhlerF1000Research|February 25, 2017
Disinhibition, an emerging pharmacology of learning and memoryHanns Möhler, Uwe RudolphAnnual Review of Pharmacology and Toxicology|January 28, 2004
Analysis of GABAA receptor function and dissection of the pharmacology of benzodiazepines and general anesthetics through mouse geneticsUwe Rudolph, Hanns MöhlerCurrent Opinion in Pharmacology|December 27, 2005
GABA-based therapeutic approaches: GABAA receptor subtype functionsUwe Rudolph, Hanns MöhlerPharmacology, Biochemistry, and Behavior|May 6, 2008
Regulation of cognition and symptoms of psychosis: focus on GABA(A) receptors and glycine transporter 1Hanns Möhler, Uwe Rudolph, Detlev Boison, et al.Science (New York, N.Y.)|March 16, 2004
Specific GABAA circuits for visual cortical plasticityMichela Fagiolini, Jean-Marc Fritschy, Karin Löw, et al.The European Journal of Neuroscience|September 24, 2004
GABA receptors containing the alpha5 subunit mediate the trace effect in aversive and appetitive conditioning and extinction of conditioned fearBenjamin K Yee, Jonas Hauser, Vadim V Dolgov, et al.Dialogues in Clinical Neuroscience|October 29, 2011
Pathophysiological aspects of diversity in neuronal inhibition: a new benzodiazepine pharmacologyHanns MöhlerAdvances in Pharmacology (San Diego, Calif.)|January 21, 2015
The legacy of the benzodiazepine receptor: from flumazenil to enhancing cognition in Down syndrome and social interaction in autismHanns MöhlerPageof 17